1
|
Ionescu RE. Updates on the Biofunctionalization of Gold Nanoparticles for the Rapid and Sensitive Multiplatform Diagnosis of SARS-CoV-2 Virus and Its Proteins: From Computational Models to Validation in Human Samples. Int J Mol Sci 2023; 24:ijms24119249. [PMID: 37298201 DOI: 10.3390/ijms24119249] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2023] [Revised: 05/19/2023] [Accepted: 05/22/2023] [Indexed: 06/12/2023] Open
Abstract
Since the outbreak of the pandemic respiratory virus SARS-CoV-2 (COVID-19), academic communities and governments/private companies have used several detection techniques based on gold nanoparticles (AuNPs). In this emergency context, colloidal AuNPs are highly valuable easy-to-synthesize biocompatible materials that can be used for different functionalization strategies and rapid viral immunodiagnosis. In this review, the latest multidisciplinary developments in the bioconjugation of AuNPs for the detection of SARS-CoV-2 virus and its proteins in (spiked) real samples are discussed for the first time, with reference to the optimal parameters provided by three approaches: one theoretical, via computational prediction, and two experimental, using dry and wet chemistry based on single/multistep protocols. Overall, to achieve high specificity and low detection limits for the target viral biomolecules, optimal running buffers for bioreagent dilutions and nanostructure washes should be validated before conducting optical, electrochemical, and acoustic biosensing investigations. Indeed, there is plenty of room for improvement in using gold nanomaterials as stable platforms for ultrasensitive and simultaneous "in vitro" detection by the untrained public of the whole SARS-CoV-2 virus, its proteins, and specific developed IgA/IgM/IgG antibodies (Ab) in bodily fluids. Hence, the lateral flow assay (LFA) approach is a quick and judicious solution to combating the pandemic. In this context, the author classifies LFAs according to four generations to guide readers in the future development of multifunctional biosensing platforms. Undoubtedly, the LFA kit market will continue to improve, adapting researchers' multidetection platforms for smartphones with easy-to-analyze results, and establishing user-friendly tools for more effective preventive and medical treatments.
Collapse
Affiliation(s)
- Rodica Elena Ionescu
- Light, Nanomaterials and Nanotechnology (L2n) Laboratory, CNRS EMR 7004, University of Technology of Troyes, 12 Rue Marie Curie, CS 42060, CEDEX, 10004 Troyes, France
| |
Collapse
|
2
|
Azizan A, Samsudin AA, Shamshul Baharin MB, Dzulkiflee MH, Rosli NR, Abu Bakar NF, Adlim M. Cellulosic fiber nanocomposite application review with zinc oxide antimicrobial agent nanoparticle: an opt for COVID-19 purpose. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2023; 30:16779-16796. [PMID: 35084685 PMCID: PMC8793331 DOI: 10.1007/s11356-022-18515-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Accepted: 01/01/2022] [Indexed: 05/08/2023]
Abstract
Cellulosic fiber (CF) in nanoform is emergingly finding its way for COVID-19 solution for instance via nanocomposite/nanoparticle from various abundant biopolymeric waste materials, which may not be widely commercialized when the pandemic strikes recently. The possibility is wide open but needs proper collection of knowledge and research data. Thus, this article firstly reviews CF produced from various lignocellulosic or biomass feedstocks' pretreatment methods in various nanoforms or nanocomposites, also serving together with metal oxide (MeO) antimicrobial agents having certain analytical reporting. CF-MeO hybrid product can be a great option for COVID-19 antimicrobial resistant environment to be proposed considering the long-established CF and MeO laboratory investigations. Secondly, a preliminary pH investigation of 7 to 12 on zinc oxide synthesis discussing on Fouriertransform infrared spectroscopy (FTIR) functional groups and scanning electron microscope (SEM) images are also presented, justifying the knowledge requirement for future stable nanocomposite formulation. In addition to that, recent precursors suitable for zinc oxide nanoparticle synthesis with emergingly prediction to serve as COVID-19 purposes via different products, aligning with CFs or nanocellulose for industrial applications are also reviewed.
Collapse
Affiliation(s)
- Amizon Azizan
- School of Chemical Engineering, College of Engineering, Universiti Teknologi MARA, 40450, Shah Alam, Selangor, Malaysia.
| | - Aisyah Afiqah Samsudin
- School of Chemical Engineering, College of Engineering, Universiti Teknologi MARA, 40450, Shah Alam, Selangor, Malaysia
| | | | - Muhammad Harith Dzulkiflee
- School of Chemical Engineering, College of Engineering, Universiti Teknologi MARA, 40450, Shah Alam, Selangor, Malaysia
| | - Nor Roslina Rosli
- School of Chemical Engineering, College of Engineering, Universiti Teknologi MARA, 40450, Shah Alam, Selangor, Malaysia
| | - Noor Fitrah Abu Bakar
- School of Chemical Engineering, College of Engineering, Universiti Teknologi MARA, 40450, Shah Alam, Selangor, Malaysia
| | - Muhammad Adlim
- Graduate School of Mathematics and Applied Science, Universitas Syiah Kuala, 23111 Darussalam Banda Aceh, Kuala, Indonesia
- Chemistry Department, FKIP, Universitas Syiah Kuala, 23111 Darussalam Banda Aceh, Kuala, Indonesia
| |
Collapse
|
3
|
Rastogi A, Singh A, Naik K, Mishra A, Chaudhary S, Manohar R, Singh Parmar A. A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS - CoV- 2 (COVID - 19). J Mol Liq 2022; 362:119795. [PMID: 35832289 PMCID: PMC9265145 DOI: 10.1016/j.molliq.2022.119795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Revised: 07/03/2022] [Accepted: 07/05/2022] [Indexed: 01/31/2023]
Abstract
The COVID-19 is a pandemic caused by the SARS-CoV-2 virus, has instigated major health problems and prompted WHO to proclaim a worldwide medical emergency. The knowledge of SARS-CoV-2 fundamental structure, aetiology, its entrance mechanism, membrane hijacking and immune response against the virus, are important parameters to develop effective vaccines and medicines. Liquid crystals integrated nano-techniques and various nanoformulations were applied to tackle the severity of the virus. It was reported that nanoformulations have helped to enhance the effectiveness of presently accessible antiviral medicines or to elicit a fast immunological response against COVID-19 virus. Applications of liquid crystals, nanostructures, nanoformulations and nanotechnology in diagnosis, prevention, treatment and tailored vaccine administration against COVID-19 which will help in establishing the framework for a successful pandemic combat are reviewed. This review also focuses on limitations associated with liquid crystal-nanotechnology based systems and suggests the possible ways to address these limitations. Also, topical advancements in the ground of liquid crystals and nanostructures established diagnostics (nanosensor/biosensor) are discussed in detail.
Collapse
Affiliation(s)
- Ayushi Rastogi
- Liquid Crystal Laboratory, Department of Physics, University of Lucknow, Lucknow 226007, Uttar Pradesh, India
- Department of Humanity and Applied Sciences (Physics), SMS College of Engineering, Institute of Technology, Lucknow 226001, Uttar Pradesh, India
| | - Abhilasha Singh
- Department of Physics, J.S.S Academy of Technical Education, Bangalore 560060, Karnataka, India
| | - Kaustubh Naik
- Indian Institute of Technology (BHU), Varanasi 221005, Uttar Pradesh, India
| | - Archana Mishra
- Nuclear Agriculture and Biotechnology Division, Bhabha Atomic Research Centre, Trombay - 400085, Mumbai, India
| | - Shilpi Chaudhary
- Department of Applied Sciences, Punjab Engineering College (Deemed to be University), Chandigarh 160012, Punjab, India
| | - Rajiv Manohar
- Liquid Crystal Laboratory, Department of Physics, University of Lucknow, Lucknow 226007, Uttar Pradesh, India
| | | |
Collapse
|
4
|
Rapid and efficient testing of the toxicity of graphene-related materials in primary human lung cells. Sci Rep 2022; 12:7664. [PMID: 35538131 PMCID: PMC9088729 DOI: 10.1038/s41598-022-11840-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2021] [Accepted: 04/28/2022] [Indexed: 11/25/2022] Open
Abstract
Graphene and its derivative materials are manufactured by numerous companies and research laboratories, during which processes they can come into contact with their handlers' physiological barriers—for instance, their respiratory system. Despite their potential toxicity, these materials have even been used in face masks to prevent COVID-19 transmission. The increasingly widespread use of these materials requires the design and implementation of appropriate, versatile, and accurate toxicological screening methods to guarantee their safety. Murine models are adequate, though limited when exploring different doses and lengths of exposure—as this increases the number of animals required, contrary to the Three R's principle in animal experimentation. This article proposes an in vitro model using primary, non-transformed normal human bronchial epithelial (NHBE) cells as an alternative to the most widely used model to date, the human lung tumor cell line A549. The model has been tested with three graphene derivatives—graphene oxide (GO), few-layer graphene (FLG), and small FLG (sFLG). We observed a cytotoxic effect (necrosis and apoptosis) at early (6- and 24-h) exposures, which intensified after seven days of contact between cells and the graphene-related materials (GRMs)—with cell death reaching 90% after a 5 µg/mL dose. A549 cells are more resistant to necrosis and apoptosis, yielding values less than half of NHBE cells at low concentrations of GRMs (between 0.05 and 5 µg/mL). Indeed, GRM-induced cell death in NHBE cells is comparable to that induced by toxic compounds such as diesel exhaust particles on the same cell line. We propose NHBE as a suitable model to test GRM-induced toxicity, allowing refinement of the dose concentrations and exposure timings for better-designed in vivo mouse assays.
Collapse
|
5
|
Fritea L, Banica F, Costea TO, Moldovan L, Dobjanschi L, Muresan M, Cavalu S. Metal Nanoparticles and Carbon-Based Nanomaterials for Improved Performances of Electrochemical (Bio)Sensors with Biomedical Applications. MATERIALS (BASEL, SWITZERLAND) 2021; 14:6319. [PMID: 34771844 PMCID: PMC8585379 DOI: 10.3390/ma14216319] [Citation(s) in RCA: 43] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Revised: 10/15/2021] [Accepted: 10/20/2021] [Indexed: 12/30/2022]
Abstract
Monitoring human health for early detection of disease conditions or health disorders is of major clinical importance for maintaining a healthy life. Sensors are small devices employed for qualitative and quantitative determination of various analytes by monitoring their properties using a certain transduction method. A "real-time" biosensor includes a biological recognition receptor (such as an antibody, enzyme, nucleic acid or whole cell) and a transducer to convert the biological binding event to a detectable signal, which is read out indicating both the presence and concentration of the analyte molecule. A wide range of specific analytes with biomedical significance at ultralow concentration can be sensitively detected. In nano(bio)sensors, nanoparticles (NPs) are incorporated into the (bio)sensor design by attachment to the suitably modified platforms. For this purpose, metal nanoparticles have many advantageous properties making them useful in the transducer component of the (bio)sensors. Gold, silver and platinum NPs have been the most popular ones, each form of these metallic NPs exhibiting special surface and interface features, which significantly improve the biocompatibility and transduction of the (bio)sensor compared to the same process in the absence of these NPs. This comprehensive review is focused on the main types of NPs used for electrochemical (bio)sensors design, especially screen-printed electrodes, with their specific medical application due to their improved analytical performances and miniaturized form. Other advantages such as supporting real-time decision and rapid manipulation are pointed out. A special attention is paid to carbon-based nanomaterials (especially carbon nanotubes and graphene), used by themselves or decorated with metal nanoparticles, with excellent features such as high surface area, excellent conductivity, effective catalytic properties and biocompatibility, which confer to these hybrid nanocomposites a wide biomedical applicability.
Collapse
Affiliation(s)
- Luminita Fritea
- Faculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania; (L.F.); (F.B.); (M.M.); (S.C.)
| | - Florin Banica
- Faculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania; (L.F.); (F.B.); (M.M.); (S.C.)
| | - Traian Octavian Costea
- Advanced Materials Research Infrastructure—SMARTMAT, University of Oradea, 1 Universitatii Street, 410087 Oradea, Romania;
| | - Liviu Moldovan
- Faculty of Electrical Engineering and Information Technology, University of Oradea, 1 Universitatii Street, 410087 Oradea, Romania
| | - Luciana Dobjanschi
- Faculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania; (L.F.); (F.B.); (M.M.); (S.C.)
| | - Mariana Muresan
- Faculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania; (L.F.); (F.B.); (M.M.); (S.C.)
| | - Simona Cavalu
- Faculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania; (L.F.); (F.B.); (M.M.); (S.C.)
| |
Collapse
|
6
|
Yayehrad AT, Siraj EA, Wondie GB, Alemie AA, Derseh MT, Ambaye AS. Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives. Int J Nanomedicine 2021; 16:5713-5743. [PMID: 34465991 PMCID: PMC8402990 DOI: 10.2147/ijn.s327334] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Accepted: 07/29/2021] [Indexed: 12/21/2022] Open
Abstract
A serious viral infectious disease was introduced to the globe by the end of 2019 that was seen primarily from China, but spread worldwide in a few months to be a pandemic. Since then, accurate prevention, early detection, and effective treatment strategies are not yet outlined. There is no approved drug to counter its worldwide transmission. However, integration of nanostructured delivery systems with the current management strategies has promised a pronounced opportunity to tackle the pandemic. This review addressed the various promising nanotechnology-based approaches for the diagnosis, prevention, and treatment of the pandemic. The pharmaceutical, pharmacoeconomic, and regulatory aspects of these systems with currently achieved or predicted beneficial outcomes, challenges, and future perspectives are also highlighted.
Collapse
Affiliation(s)
- Ashagrachew Tewabe Yayehrad
- Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia
| | - Ebrahim Abdela Siraj
- Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia
| | - Gebremariam Birhanu Wondie
- Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| | - Atlaw Abate Alemie
- Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- Ethiopian Food and Drug Authority (EFDA), Federal Ministry of Health (FMoH), Addis Ababa, Ethiopia
| | - Manaye Tamrie Derseh
- Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- Departement of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, Mizan-Tepi University, Mizan-Aman, Ethiopia
| | - Abyou Seyfu Ambaye
- Departement of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, Mizan-Tepi University, Mizan-Aman, Ethiopia
| |
Collapse
|